Thorough QT cardiac safety study of pyridoxamine
Phase of Trial: Phase I
Latest Information Update: 05 Jan 2015
At a glance
- Drugs Pyridoxamine (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions
- Sponsors NephroGenex
- 05 Jan 2015 New trial record
- 30 Dec 2014 Results published in a NephroGenex media release.
- 30 Dec 2014 This trial has been completed, according to a NephroGenex media release.